US Patent 9913884 HLA-A2 tumor associated antigen peptides and compositions

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

99138840

Patent Inventor Names

John D. Fikes0

Alessandro Sette0

Glenn Ishioka0

Robert W. Chesnut0

Date of Patent

March 13, 2018

Patent Application Number

151959360

Date Filed

June 28, 2016

Patent Citations Received

‌

US Patent 12064475 Compositions and method for optimized peptide vaccines using residue optimization

‌

US Patent 12091443 Method of compact peptide vaccines using residue optimization

Patent Primary Examiner

‌

Karen Canella

Patent abstract

A peptide or composition comprising at least one HLA-A2 epitope or analog from CEA, HER2/neu, MAGE2, MAGE3, or p53.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9913884 HLA-A2 tumor associated antigen peptides and compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API